Appropriate vs. inappropriate antimicrobial therapy

Clinical Microbiology and Infection

Volumn 14, Issue SUPPL. 3, 2008, Pages 15-21

  Davey, P G ^a   Marwick, C ^a  

^a Mackenzie Building   (United Kingdom)

Author keywords

Antibacterial agents; Cost; Nosocomial infection; Outcome assessment; Review; Ventilator associated pneumonia

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTAXIME; PENICILLIN G;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; AWARENESS; BACTEREMIA; BACTERIAL INFECTION; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EMPIRICISM; FUNCTIONAL STATUS; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; LENGTH OF STAY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 40449136746     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.01959.x     Document Type: Review

References (15)

1. Luna CM. Vujacich P. Niederman MS Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia Chest 111 1997 676 685
2. Mosdell DM. Morris DM. Voltura A Antibiotic treatment for surgical peritonitis Ann Surg 214 1991 543 549
3. Ibrahim EH. Sherman G. Ward S. Fraser VJ. Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Chest 118 2000 146 155
4. Lodise TP. McKinnon PS. Swiderski L. Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia Clin Infect Dis 36 2003 1418 1423
5. Leibovici L. Shraga I. Drucker M. Konigsberger H. Samra Z. Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection J Intern Med 244 1998 379 386
6. Das I. Jumaa P. Has the severity of Clostridium difficile infections increased J Hosp Infect 65 2007 85 86
7. Heyland DK. Cook DJ. Griffith L. Keenan SP. Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group Am J Respir Crit Care Med 159 1999 1249 1256
8. Paul M. Andreassen S. Tacconelli E Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial J Antimicrob Chemother 58 2006 1238 1245
9. Howard D. Cordell R. McGowan JE Jr Packard RM. Scott RD 2nd Solomon SL. Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention-Emory Workshop Clin Infect Dis 33 2001 1573 1578
10. McGowan JE Jr. Economic impact of antimicrobial resistance Emerg Infect Dis 7 2001 286 292
11. Millar MR. Brown NM. Tobin GW. Murphy PJ. Windsor AC. Speller DC. Outbreak of infection with penicillin-resistant Streptococcus pneumoniae in a hospital for the elderly J Hosp Infect 27 1994 99 104
12. Blot SI. Vandewoude KH. Hoste EA. Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus Arch Intern Med 162 2002 2229 2235
13. Wangler M. Beyersmann J. Schumacher M. ChangeLOS: an R-package for change in length of hospital stay based on the Aalen-Johansen estimator R News 6 2006 31 35
14. Beyersmann J. Gastmeier P. Grundmann H Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection Infect Control Hosp Epidemiol 27 2006 493 499
15. Lipsitch M. Bergstrom CT. Levin BR. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions Proc Natl Acad Sci USA 97 2000 1938 1943